IGF-1 Endurance Plus (AnuMed International LLC)


Welcome to the PulseAid listing for the IGF-1 Endurance Plus drug offered from AnuMed International LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: AnuMed International LLC
NON-PROPRIETARY NAME: insulin-like growth factor-1 (IGF-1)
SUBSTANCE NAME: MECASERMIN
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2011-05-01
END MARKETING DATE: 0000-00-00


IGF-1 Endurance Plus HUMAN OTC DRUG Details:

Item DescriptionIGF-1 Endurance Plus from AnuMed International LLC
LABELER NAME: AnuMed International LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_C]/30mL)
START MARKETING DATE: 2011-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50970-003_1049d373-8b88-49fa-a4ca-8461e8b24247
PRODUCT NDC: 50970-003
APPLICATION NUMBER:

Other MECASERMIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnuMed International LLCIGF-1 Endurance Plus
Guna spaGUNA-IGF
Ipsen Biopharmaceuticals, Inc.Increlex